This study estimated latent classes (ie, unobserved subgroups in a population) of people who use drugs in Vancouver, Canada, and examined how these classes relate to phylogenetic clustering of hepatitis C virus (HCV) infection. HCV antibody-positive people who use drugs from two cohorts in Vancouver, Canada (1996, with a Core-E2 sequence were included. Time-stamped phylogenetic trees were inferred, and phylogenetic clustering was determined by time to most common recent ancestor.
| INTRODUCTION
Infection with hepatitis C virus (HCV) disproportionately affects people who use drugs (PWUD), and HCV incidence remains particularly high among drug-using youth and young adults. [1] [2] [3] While the factors associated with HCV acquisition are well described, the dynamics of HCV transmission are poorly understood. Phylogenetic clustering has been used as a tool to better understand characteristics that might be associated with increased likelihood of HCV transmission. [4] [5] [6] [7] However, little is known about the association between drug use patterns and phylogenetic clustering of HCV infection PWUD. Understanding the association between drug use patterns and HCV transmission would help to better target HCV prevention strategies.
In studies of HCV transmission among cohorts of people who use drugs in Vancouver, Canada, younger age, HIV infection, recent HCV seroconversion and syringe borrowing have been shown to be independently associated with phylogenetic clustering. 4, 5 In a recently published study, methamphetamine injecting was also shown to be associated with HCV clustering among a small sample of young PWUD in Vancouver. Latent class analysis (LCA) divides a population into mutually exclusive and exhaustive subgroups, simultaneously examining sociodemographic covariates associated with these patterns. 9 The method assumes that the population is composed of distinct subpopulations (ie, latent classes), which are not directly observed but are inferred from the observed characteristics of individuals. 10 Patterns of illicit drug use defined by LCA have been used to describe participant risk of HIV and HCV infections, substance abuse treatment utilization and quality of life. [11] [12] [13] Recently, LCA has been combined with phylogenetic analysis to better understand the dynamics of HIV transmission in Switzerland and to characterize the propensity for clustering both within and between socioeconomic groupings.
14 Next-generation direct-acting antiviral HCV therapies are well tolerated and highly efficacious among people who actively use drugs and may be useful in a treatment as prevention strategy. 15, 16 However, limited access to these novel therapies may necessitate targeted implementation. Given the complex nature of HCV transmission, gaining a better understanding of drug use patterns and their relationship to HCV transmission may inform the development of public health interventions.
The aim of this study was to identify patterns of polydrug use using LCA and to evaluate the association between drug uses classes and HCV phylogenetic cluster membership among two cohorts of people who use drugs in Vancouver.
| MATERIALS AND METHODS

| Study population and design
The study population and design, study assessments, RNA sequencing, and phylogenetic analyses have been previously described. 
| Phylogenetic analysis
HCV RNA was quantified using an in-house PCR (limit of detection:
200 IU/mL), and amplification and sequencing of a 1514-bp fragment of the HCV genome covering Core, Envelope-1, hypervariable region-1 and beginning of Envelope-2 (E2) was attempted on all samples with detectable HCV RNA. 19 Sanger sequencing chromatograms were processed using RECall, 20 and phylogenetic trees were inferred for participants with HCV subtypes 1a, 1b, 2a and 3a using a Bayesian phylogenetic approach implemented in BEAST v1.8.1. 21 Initially, a genomic-partition model was employed to estimate the substitution rates of Core-E2 region from an independent HCV data set, which exhibited a strong temporal signal. 22 These rates were subsequently applied as a strong prior distribution on the molecular clock to estimate time-scaled phylogenies based on sequences generated in this study.
Clusters and pairs were identified using a new method that placed an upper limit on the estimated time to most common recent ancestor (tMRCA) of potentially connected individuals (ClusterByTime, http:// evolve.zoo.ox.ac.uk/Evolve/ClusterByTime.html). To account for phylogenetic uncertainty, 100 phylogenies from the posterior tree distribution were assessed with a tMRCA limit of 5 years. 5 Sensitivity analysis of phylogenetic clustering and factors associated identified correspondence between 5-year tMRCA limit and a 1.5% genetic distance threshold. 
| Latent class estimation
In this LCA, the latent class variable represents categories of underlying drug use behaviour. A total of six binary observed indicators (all yes vs no) were used to estimate the latent class variable: heroin injecting, cocaine injecting, speedball (ie, simultaneous heroin/cocaine) injecting, crack smoking, current enrolment in opioid substitution therapy programme (OST: methadone), as well as a combined variable representing nonmedical use of prescription opioids (eg, hydromorphone, morphine and/or methadone). Reported drug use relates to the past 6 months at time of interview. Preliminary LCA models were estimated to identify a model with the optimal number of classes, increasing from one to eight classes without covariates, as has previously been described. 23 Model fit was estimated using Akaike information criterion (AIC), Bayesian information criterion (BIC), 
| Statistical analyses
The aim of this study was to assess the association between latent class membership and phylogenetic clustering. An inclusive classifyanalyse estimate of the association was implemented to reduce model attenuation and bias during classification. 25 Participants were assigned to the latent class corresponding to their most likely membership (ie, their maximum posterior probability), with the class-specific proportions for the phylogenetic clustering calculated and class membership treated as an observed variable in logistic regression against phylogenetic clustering.
Descriptive analyses were performed to characterize the study sample according to being in a pair or cluster (n≥2 participants), or neither. Participant characteristics in these categories were compared using chi-squared, Fisher's exact and Kruskal-Wallis tests (as appropriate). Statistically significant differences were assessed at P<.05; all P-values are two-sided. Descriptive and inclusive classify-analyse logistic regression analyses were performed using STATA software (version 12.1; StataCorp L.P., College Station, TX, USA), and latent class analyses (classification and distal outcomes) were performed using PROC LCA within SAS software (version 9.4; SAS Institute Inc., Cary, NC, USA).
| RESULTS
| Study population
In total, 2688 participants from the ARYS (n=961) and VIDUS (Table 1) . HCV genotype distribution was as follows: 1a: 48% (n=347), 1b: 6% (n=44), 2a:
3% (n=20), 2b: 7% (n=52), 3a: 35% (n=256), 4a: <1% (n=4), 6a: 1% (n=8), 6e: <1% (n=1).
| Phylogenetic analysis
As previously reported, 5 phylogenetic analysis was performed on participants with 1a, 1b, 2b and 3a infections, comprising 95% of participants (699 of 732) with an identifiable subtype. Among those analysed, 22% (n=150) were younger (aged <27 years), while 10% (n=73) had recent HCV seroconversion. A total of 108 (15%) participants had close genetic relatedness, with 87 in pairs (two participants, n=44 pairs, 12%) and 21 in clusters (≥3 participants, n=6 clusters, 3%)
if the most common recent ancestor of the participants (inferred) was <5 years in the past. Pair/cluster sizes ranged from two to six participants (median: 2).
| Latent class estimation
Preliminary latent class estimation identified a three class solution as optimal solution for underlying drug use behaviours according to the BIC, aBIC and cAIC model fit statistics ( Table 2 ). The AIC statis- Based on the item response probabilities, the four classes were named according to the relative behaviours of the participants (Table 3 ). The group with the highest class probability (0.31, standard error [SE] 0.05) was termed "Opioid and cocaine injecting," while the class probability for "Cocaine injecting" was 0.28 (SE 0.05). A similar class probability was found for "Heroin with current OST" (0.23, SE 0.06), and the lowest class probability was the "Crack cocaine smoking" group (0.18, SE 0.06).
| Distal outcome analysis
Fifteen per cent of participants (n=108 of 699) were previously found to have close viral genetic relatedness (phylogenetic clustering).
5
Latent drug use class was related to odds of phylogenetic cluster membership when assessed by an inclusive classify/analyse methodology (Table 4 ).
In the inclusive classify/analyse logistic regression model, relative to those in the heroin injecting with current OST group, those in the 
| DISCUSSION
This study characterizes the association between drug use patterns and HCV phylogenetic clustering among two cohorts of people who use drugs recruited between 1996 and 2012 in Vancouver, Canada.
Latent class analysis identified four distinct patterns of drug use that included (i) cocaine injecting, (ii) opioid and cocaine injecting, (iii) crack cocaine smoking and (iv) heroin injecting and currently receiving OST.
After adjusting for HIV infection and age, membership in the heroin injecting with current OST group was independently associated with an increased likelihood of HCV phylogenetic clustering, while membership in the crack cocaine smoking class was associated with a decreased likelihood of phylogenetic clustering. This is the first study to across studies involving PWUD. However, similar to the current study, distinct classes of people who use drugs have been identified using LCA in Baltimore, 10, 11 San Diego, 26 Montreal, 27 in other parts of Canada 28 and the USA. To our knowledge, this study is among the first to demonstrate that patterns of polydrug use were associated with differing risk of HCV phylogenetic clustering. Compared to participants in the heroin injection and currently receiving OST class, those in the cocaine injecting class had greater odds of HCV infection being closely genetically related to another participant. This is consistent with data demonstrating that acquisition of HCV is associated with recent injecting of cocaine, perhaps a function of the increased number of injections per day compared to heroin. 30, 31 Within the VIDUS study, cocaine injecting was associated with a shorter time to HCV seroconversion. 32 In the current study, the cocaine injecting class had the lowest probability of participants currently receiving OST, a harm reduction measure known to prevent HCV infection. [33] [34] [35] The high number of daily injections associated with cocaine injecting and the absence of evidence-based pharmacotherapies for cocaine use disorder in this subgroup may explain the association between membership in the cocaine injecting latent class and HCV phylogenetic clustering in this cohort.
In the current study, the crack cocaine smoking class had significantly reduced odds of phylogenetic clustering. Injecting heroin and cocaine remained high in this group; however, smoking crack cocaine had the highest probability of use and injecting speedball was low.
Cessation of injecting is effective at eliminating the risk of HCV acquisition. 36 In addition, exclusive crack cocaine smoking is associated with cessation of injecting. 37 A significant increase in crack cocaine smoking was seen in the VIDUS cohort from 1996 to 2012, 32 and previous data have demonstrated frequent cocaine injecting and methamphetamine injecting as being independent predictors of crack cocaine initiation. 38 While crack cocaine smoking is associated with serious health and social problems including prevalent HCV infection, [39] [40] [41] [42] a reduction in injecting behaviour may mitigate onward transmission of HCV among this population. Similar to needle and syringe programmes, improving access to safer crack-smoking equipment and facilities would likely reduce harms associated with both drug injecting and smoking and improve individual and community health outcomes. 40, 43, 44 This study has a number of limitations. Although data collection and study instruments were harmonized, the VIDUS and ARYS cohorts had differences in inclusion and exclusion criteria. To help mitigate po- OST, opioid substitution therapy. Proportions of participants not in a cluster or in a cluster relate to column total.
T A B L E 4 Inclusive classify/analyse logistic adjusted logistic regression analysis from the four-class latent class analysis solution of drug use among people who use drugs in Vancouver, Canada (n=699)
Nonetheless, LCA provides a useful mechanism for representing the heterogeneity of factors across the population. Lastly, information on all behaviours was collected by self-report and may be subject to response biases.
The data from the current study suggest that people with ongoing cocaine injecting should be targeted with respect to treatment and prevention activities. Mathematical modelling of targeted HCV treatment and prevention interventions suggests that combining highcapacity needle and syringe programme access with OST and DAA HCV therapies would significantly reduce HCV acquisition in the future. 45, 46 Additionally, modelling suggests that expanding treatment to immediate injecting partners in a network of people who inject drugs (eg, "bring a friend approach") is favourable to a random treatment strategy. 47 The outcomes from the current study should be used to inform future mathematical modelling studies and the development of treatment and prevention interventions.
In conclusion, this study of people who use drugs in Vancouver demonstrates that there are identifiable patterns of polydrug use, with differing degrees of HCV phylogenetic clustering seen in the groups.
LCA provides a framework to better understand the complex dynamics of drug use, particularly when multiple drug types are used. An enhanced understanding of HCV transmission dynamics should be used to inform future treatment and prevention strategies, particularly towards those at greatest risk of transmission.
